SCHEDULE: First Manhattan Discloses 9.6% Stake in PAVmed Inc.

First Manhattan Co. LLC, FMC Group Holdings LP, and First Manhattan Management LLC collectively report beneficial ownership of 9.6% of PAVmed Inc.'s common stock as of March 31, 2026.

Summary

• First Manhattan Co. LLC, FMC Group Holdings LP, and First Manhattan Management LLC have filed a Schedule 13G, indicating their beneficial ownership of PAVmed Inc. common stock.
• The filing, dated March 31, 2026, shows an aggregate of 639,191 shares beneficially owned, representing 9.6% of the class.
• The reporting entities are organized in Delaware and operate from 399 Park Avenue, New York, NY 10022.
• Each entity holds sole voting and dispositive power over 638,720 shares and shared voting and dispositive power over 471 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports ownership stakes rather than company performance or strategic changes.

Positives

• Significant ownership stake (9.6%) by established financial entities suggests confidence in PAVmed Inc.'s prospects.
• The reporting entities are registered under Section 15 of the Securities Exchange Act of 1934, indicating they are brokers or dealers, implying a professional and regulated approach to their holdings.

Negatives

• The filing does not provide specific financial performance data for PAVmed Inc., only ownership details.

Risks

• Potential for increased market influence by a significant shareholder could lead to changes in corporate strategy or governance.
• The nature of the reporting entities as brokers/dealers and investment advisors means their holdings could be subject to market dynamics and client needs.

Future Outlook

The filing itself is a disclosure of current ownership and does not contain forward-looking statements or guidance from PAVmed Inc.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and indicate significant stakes in publicly traded companies. This filing shows a substantial position taken by First Manhattan entities in PAVmed Inc., a company operating in the healthcare technology sector.

Stakeholder Impact

• Shareholders: The increased stake by First Manhattan entities may signal increased institutional interest, potentially impacting share price and liquidity. It could also indicate a belief in the company's future value.
• Management of PAVmed Inc.: May need to engage with significant shareholders regarding corporate strategy and governance.
• Potential Investors: The filing provides transparency on major shareholders, which is a factor in investment analysis.

Next Steps

• Monitor future filings from First Manhattan entities for any changes in their beneficial ownership of PAVmed Inc.
• Observe PAVmed Inc.'s corporate actions and strategic announcements for potential influence from significant shareholders.

Key Dates

Keywords

PAVmed Inc., Schedule 13G, First Manhattan Co. LLC, FMC Group Holdings LP, First Manhattan Management LLC, Beneficial Ownership, Common Stock, SEC Filing, Securities Exchange Act